This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase Ib, open-label, multicenter study to inves...
Clinical trial

A phase Ib, open-label, multicenter study to investigate the pharmacokinetics, pharmacodynamics, and safety of tocilizumab following subcutaneous administration to patients with polyarticular-course juvenile idiopathic arthritis

Read time: 1 mins
Last updated:20th Jun 2013
The primary objective is to characterize the pharmacokinetics of subcutaneous tocilizumab (SC TCZ) in patients with pcJIA.
Category Value
Study start date 2013-06-20

View full details